Anticancer Res

1. AMANO Y, Matsubara D, Kihara A, Yoshimoto T, et al
   The Significance of Phosphorylated Yes-associated Protein (YAP) (Ser 127) Expression in Oral Squamous Cell Carcinoma.
   Anticancer Res. 2025;45:3835-3845.
   

   >> Share

   
   
2. SATO F, Ono T, Hiraki A, Oka T, et al
   Prognostic Value of the C-Reactive Protein-albumin-lymphocyte Index For Patients With Recurrent omicronr Metastatic Head and Neck Squamous Cell Carcinoma Treated With Nivolumab.
   Anticancer Res. 2025;45:3993-4004.
   

   >> Share

   
   
3. HIROTA J, Takeda D, Sadakane Y, Matsuzoe Y, et al
   TGF-B-induced Cancer-associated Fibroblast Activation Promotes Tumor Progression In Oral Squamous Cell Carcinoma Mouse Model.
   Anticancer Res. 2025;45:3687-3700.
   

   >> Share

   
   
4. SUZUKI H, Taniguchi H, Inaba Y, Tachibana H, et al
   Survival Outcome for Peptide Receptor Radionuclide Therapy in Olfactory Neuroblastoma.
   Anticancer Res. 2025;45:3877-3884.
   

   >> Share

   
   
5. ANZELLINI D, Loddo M, Del Bianco S
   Long-lasting Complete Remission Following Immunotherapy With Anti-PD1 Plus Anti-CTLA4 in a Polymetastatic Patient With NRAS (Q16R) Mutated Anaplastic Thyroid Carcinoma.
   Anticancer Res. 2025;45:3809-3816.
   

   >> Share

   
   
6. YANG TL, Chen PH, Lee HL, Jhou HJ, et al
   Tegafur-uracil as a Maintenance Therapy for Non-metastatic Nasopharyngeal Carcinoma: Insights from the Literature.
   Anticancer Res. 2025;45:3617-3628.
   

   >> Share

   
   

   
   BMC Cancer

7. YUAN J, Gu J, Ding M, Jin X, et al
   Protection of parathyroid function during thyroid surgery with a complete intermediate approach: a retrospective multicenter observational study.
   BMC Cancer. 2025;25:1309.
   

   >> Share

   
   
8. LIU Y, Han B
   Global, regional, and national burden trends of lip and oral cavity cancer among individuals aged 60 and above from 1990 to 2021: a systematic analysis based on the 2021 global burden of disease data.
   BMC Cancer. 2025;25:1322.
   

   >> Share

   
   
9. ANGUERA G, Gallego O, Llobet M, Berga N, et al
   Opening of a phase Ib/II study to investigate the safety and efficacy of Afatinib in patients with Fanconi anemia and unresectable locally advanced or metastatic head and neck squamous cell carcinoma.
   BMC Cancer. 2025;25:1374.
   

   >> Share

   
   
10. ZHANG H, Zhang B, Jiang Q, Wu B, et al
    Radical surgery versus definitive radiotherapy in treatment of locoregional upper esophageal squamous cell carcinoma.
    BMC Cancer. 2025;25:1382.
    

    >> Share

    
    
11. LIU W, Ge D, Wang T, Zhao M, et al
    Salvage involved-field versus extended-field chemoradiotherapy for postoperative lymph node metastasis in esophageal squamous cell carcinoma: a retrospective clinical study.
    BMC Cancer. 2025;25:1390.
    

    >> Share

    
    

    
    Br J Cancer

12. LAN K, Li S, Jia G, Li S, et al
    Correction: Biomarkers of response to camrelizumab combined with apatinib: an analysis from a phase II trial in recurrent/metastatic nasopharyngeal carcinoma.
    Br J Cancer. 2025 Aug 27. doi: 10.1038/s41416-025-03077.
    

    >> Share

    
    

    
    Dis Esophagus

13. TANKEL J, Amin S, Katz A, Sakalla R, et al
    Gastric conduit necrosis following esophagectomy: is conduit salvage feasible?
    Dis Esophagus. 2025;38:doaf066.
    

    >> Share

    
    

    
    Head Neck

14. LEE J, Ding T, Wimbiscus M, Liu D, et al
    Neck Dissection Reduces Risk of Recurrence in Early-Stage Oral Tongue Cancer.
    Head Neck. 2025 Aug 28. doi: 10.1002/hed.70017.
    

    >> Share

    
    

    
    Oral Oncol

15. RAHMAN R, Sheikh I, Merchant Y, Mathur A, et al
    Oral cancer screening in India: a secondary analysis of disparities using national family health survey data.
    Oral Oncol. 2025;169:107632.
    

    >> Share

    
    
16. TANG Y, Jin Q, Gan X
    Comment on "Social health at 5 years after diagnosis of head and neck cancer".
    Oral Oncol. 2025;169:107627.
    

    >> Share

    
    
17. BOSSI P, Kiyota N, Mesia R, Rosenberg AJ, et al
    Adverse event profiles and management of cisplatin-based chemoradiotherapy in locally advanced head and neck squamous cell carcinoma: a systematic review.
    Oral Oncol. 2025;169:107596.
    

    >> Share

    
    
18. MISRA SR, Das R
    Insights on: "Social health at 5 years after diagnosis in head and neck cancer Survivors".
    Oral Oncol. 2025;169:107637.
    

    >> Share

    
    
19. HUANG X, Gu X
    Comment on Lung immune prognostic index is associated with clinical outcomes in recurrent or metastatic (R/M) nasopharyngeal carcinoma receiving immunotherapy: Results from the multicenter, single-arm, phase 2 study.
    Oral Oncol. 2025;169:107626.
    

    >> Share

    
    
20. CAO J, Han W, Liu Y
    Letter to the editor: effects of diagnostic delays in head and neck cancer patients presenting to the emergency department.
    Oral Oncol. 2025;169:107624.
    

    >> Share

    
    
21. HUANG J, Yan X, Wang S, Huang S, et al
    Improvements to the LEF Self-Management study for head and neck cancer survivors - Letter on Deng et al.
    Oral Oncol. 2025;169:107639.
    

    >> Share

    
    

    
    Otolaryngol Head Neck Surg

22. HAN EJ, Alhiyari Y, Evans LK, Cronkite DA, et al
    Dynamic Optical Contrast Imaging for the Pathological Diagnosis of Thyroid Cancer.
    Otolaryngol Head Neck Surg. 2025;173:586-591.
    

    >> Share

    
    
23. ABDUL-RAHMAN NH, Harris MK, Bottegal M, Sridharan S, et al
    Incidence, Morbidity, and Mortality of Pulmonary Complications in Free Flap Reconstruction: Limitations of Predictive Models.
    Otolaryngol Head Neck Surg. 2025;173:603-612.
    

    >> Share

    
    
24. ROURK KS, Calcano GA, Ali HM, Glasgow AE, et al
    Trends in the Extent of Surgical Management for Low-Grade Parotid Malignancies: A SEER Analysis.
    Otolaryngol Head Neck Surg. 2025;173:671-680.
    

    >> Share

    
    
25. KARA H, Aydemir L, Buyuk M, Bozbora E, et al
    The Importance of Extranodal Extension Grading in Laryngeal Squamous Cell Carcinoma.
    Otolaryngol Head Neck Surg. 2025;173:660-670.
    

    >> Share

    
    
26. ROURK KS, Daher GS, Schwartz JR, Ali HM, et al
    Tracking Pleomorphic Adenoma Incidence Trends Over 47 Years: A Population-Based Study.
    Otolaryngol Head Neck Surg. 2025;173:651-659.
    

    >> Share

    
    
27. HENNOCQ Q, Caruhel JB, Benassarou M, Bouaoud J, et al
    Predictive Factors of Free Flap Volume Evolution in Head and Neck Reconstruction.
    Otolaryngol Head Neck Surg. 2025;173:592-602.
    

    >> Share

    
    

    
    PLoS One

28. PREVOST A, Poncet H, Benvegnu V, Poulet V, et al
    Curative treatment incorporating subjective decisions on age and frailty is not beneficial for older patients with oral cavity squamous cell carcinoma.
    PLoS One. 2025;20:e0330376.
    

    >> Share

    
    
29. QIU L, Wu R, Chen Y, Xiang H, et al
    Dosimetry study of 3D-printed noncoplanar template-assisted CT-guided 125I seed implantation for the treatment of recurrent and metastatic tumors in the head and neck.
    PLoS One. 2025;20:e0330271.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share